Search

Search Constraints

You searched for: Author/Creator Gregg, Richard

Search Results

2. Discovery of BI 135585, an in vivo efficacious oxazinanone-based 11β hydroxysteroid dehydrogenase type 1 inhibitor. Issue 14 (15th July 2017)

4. Examining the ability of the Cancer and Aging Research Group tool to predict toxicity in older men receiving chemotherapy or androgen‐receptor–targeted therapy for metastatic castration‐resistant prostate cancer. Issue 14 (2nd April 2021)

6. Impact of treatment on elder-relevant physical function and quality of life outcomes in older adults with metastatic castration-resistant prostate cancer. Issue 1 (January 2023)

7. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Issue 10212 (23rd November 2019)

8. The role of frailty in modifying physical function and quality of life over time in older men with metastatic castration-resistant prostate cancer. Issue 2 (March 2023)